Type 1 diabetes in pregnancy: degludec vs. detemir

被引：0
|
作者：
不详
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2023年 / 18卷 / 03期
关键词：
D O I：
10.1055/a-1945-2027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In der Schwangerschaft werden Frauen mit Typ-1-Diabetes haufig mit Insulin detemir behandelt. Der Blutzuckerspiegel kann damit gut reguliert werden, ohne dass ein erhohtes Risiko fur Hypoglykamien oder Schwangerschaftskomplikationen besteht. Das neuere Insulin degludec soll ein noch besseres Wirkprofil haben als andere Insulinanaloga und ist seit kurzem auch fur Schwangere zugelassen.
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [31] Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir
    Iwasaki S.
    Kozawa J.
    Kimura T.
    Fukui K.
    Iwahashi H.
    Imagawa A.
    Shimomura I.
    Diabetology International, 2017, 8 (2) : 228 - 236
  • [32] Spotlight on insulin detemir in type 1 and 2 diabetes mellitus
    Chapman, TM
    Perry, CM
    BIODRUGS, 2005, 19 (01) : 67 - 69
  • [33] Insulin Degludec Reduces Hypoglycemia and Improves Health Status vs. Insulin Glargine in Insulin-Naive Type 2 Diabetes
    Rodbard, Helena W.
    Handelsman, Yehuda
    Cariou, Bertrand
    Johansen, Thue
    Christensen, Torsten E.
    Mathieu, Chantal
    DIABETES, 2012, 61 : A307 - A308
  • [34] Usefulness of insulin detemir in Japanese children with type 1 diabetes
    Jinno, Kazuhiko
    Urakami, Tatsuhiko
    Horikawa, Reiko
    Kawamura, Tomoyuki
    Kikuchi, Nobuyuki
    Kikuchi, Tohru
    Kizu, Rika
    Kosaka, Kitaro
    Mizuno, Haruo
    Mochizuki, Takahiro
    Nishii, Aki
    Ohki, Yukashi
    Soneda, Shun
    Sugihara, Shigetaka
    Tatematsu, Toshi
    Amemiya, Shin
    PEDIATRICS INTERNATIONAL, 2012, 54 (06) : 773 - 779
  • [35] Type 1 diabetes vaccine development Animal models vs. humans
    Boettler, Tobias
    von Herrath, Matthias
    HUMAN VACCINES, 2011, 7 (01): : 19 - 26
  • [36] PATCH PUMPS VS. DURABLE PUMPS IN CHILDREN WITH TYPE 1 DIABETES
    Danne, T.
    Remus, K.
    Blaesig, S.
    Biester, T.
    Fath, M.
    Lange, K.
    Kordonouri, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A4 - A5
  • [37] Spotlight on Insulin Detemir in Type 1 and 2 Diabetes Mellitus
    Therese M. Chapman
    Caroline M. Perry
    BioDrugs, 2005, 19 : 67 - 69
  • [38] Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes
    Iughetti, Lorenzo
    Bruzzi, Patrizia
    Maltoni, Giulio
    Zucchini, Stefano
    Graziani, Vanna
    Suprani, Tosca
    Predieri, Barbara
    DIABETES, 2017, 66 : A382 - A382
  • [39] A predictive model for type 1 vs. type 2 diabetes at presentation in pediatric populations
    Tseng, T.
    Braden, J.
    Gildengori, G.
    Johnson, J.
    Bhatia, S.
    Glaser, N.
    Noble, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 231 - 231
  • [40] The Efficacy of Insulin Degludec in Children and Adolescents with Type 1 Diabetes
    Bruzzi, Patrizia
    Maltoni, Giulio
    Predieri, Barbara
    Zucchini, Stefano
    Iughetti, Lorenzo
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 85 - 85
12345